LAURA FREEMAN: Open Payments
NPI 1528726676 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 24 payments from 9 companies in 2025. Trend: 2023 $954 · 2024 $1,418 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $90 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $72 |
| Alnylam Pharmaceuticals Inc. | 2 | $51 |
| Edwards Lifesciences Corporation | 1 | $30 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Kestra Medical Technology Services, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: Repatha, LEQVIO, LifeVest, ONPATTRO, SAPIEN 3 Ultra RESILIA, VERQUVO, Assure WCD, JARDIANCE.
Industry payments across SC — which companies pay providers there.
